Dr Edgar Hartsuiker
Senior Lecturer in Biomedical Sciences (Cancer Biology)
Cyhoeddiadau
2020
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
2019
- Cyhoeddwydjava.lang.NullPointerException
2018
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
2017
- Cyhoeddwydjava.lang.NullPointerException
2015
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
2011
- Cyhoeddwydjava.lang.NullPointerException
2010
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
2009
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
2007
- Cyhoeddwydjava.lang.NullPointerException
2006
- Cyhoeddwydjava.lang.NullPointerException
2005
- Cyhoeddwydjava.lang.NullPointerException
2004
- Cyhoeddwydjava.lang.NullPointerException
2003
- Cyhoeddwydjava.lang.NullPointerException
2002
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
2001
- Cyhoeddwydjava.lang.NullPointerException
- Cyhoeddwydjava.lang.NullPointerException
1999
- Cyhoeddwydjava.lang.NullPointerException
1998
- Cyhoeddwydjava.lang.NullPointerException
1994
- CyhoeddwydImmunocytochemical techniques applied to meiotic chromosomes
Heyting, C., Dietrich, A. J., de Jong, J. H. & Hartsuiker, E., 1994, Chromosome Analysis Protocols. Gosden, J. R. (gol.). Cyfrol 29. t. 287-302 (Methods in Molecular Biology).
Allbwn ymchwil: Pennod mewn Llyfr/Adroddiad/Trafodion Cynhadledd › Pennod › adolygiad gan gymheiriaid
Projectau
-
KESS II MRes with NWCR - BUK2E091
01/10/2022 – 31/10/2023 (Wrthi'n gweithredu)
-
KESS II Mres with NWCR in Molecular Medicine BUK2231
01/10/2022 – 31/10/2023 (Wrthi'n gweithredu)
-
KESS II MRes with North West Cancer Research BUK2222
01/01/2021 – 31/01/2022 (Wedi gorffen)
-
KESS II MRes with North West Cancer Research BUK2224
01/01/2021 – 28/02/2023 (Wedi gorffen)
-
KESS II Phd with Tenovus BUK2E004
01/03/2020 – 22/03/2023 (Wedi gorffen)
-
KESS II MRes with North West Cancer Research- BUK2176
01/10/2019 – 30/09/2021 (Wedi gorffen)
-
KESS II MRes with North West Cancer Research- BUK2175
01/10/2018 – 31/07/2020 (Wedi gorffen)
-
KESS II MRes with North West Cancer Research- BUK2177
01/10/2018 – 28/08/2020 (Wedi gorffen)
-
KESS II MRes with North West Cancer Research- BUK2178
01/10/2018 – 30/06/2022 (Wedi gorffen)
-
KESS II Phd with Tenovus Cancer Care Ltd- BUK2128
01/11/2017 – 30/09/2021 (Wedi gorffen)
-
Quantitative detection of DNA damage and nucleotides using LC/MS/MS
01/01/2016 – 30/04/2016 (Wedi gorffen)
-
Genome-wide analysis of topoisomerase removal pathways
01/09/2015 – 01/08/2019 (Wedi gorffen)
-
01/04/2015 – 01/08/2019 (Wedi gorffen)
-
01/01/2015 – 28/02/2023 (Wedi gorffen)
-
Role of Mre11 nuclease activity in replication fork progression
01/11/2014 – 31/10/2015 (Wedi gorffen)
-
Role of DNA repair in resisting treatment with Gemcitabine and other analogues
01/01/2014 – 30/06/2017 (Wedi gorffen)
-
NWCR Research Fellow in Cancer Biology
23/09/2013 – 01/08/2019 (Wedi gorffen)
-
The role of nucleotide excision repair in providing resistance to the nucleoside
01/06/2013 – 10/11/2017 (Wedi gorffen)
-
The role of the Mre11 nuclease activity in resistance to cancer drugs
01/12/2011 – 30/11/2013 (Wedi gorffen)
-
Genome-wide analysis of topoisomerase removal after camptothecin treatment
01/10/2011 – 31/12/2014 (Wedi gorffen)
-
The NISCHR Cancer Genetics Biomedical Research Unit
01/03/2011 – 01/08/2019 (Wedi gorffen)
-
01/10/2010 – 30/09/2014 (Wedi gorffen)
-
01/09/2010 – 31/08/2016 (Wedi gorffen)